BIONIC: biological network integration using convolutions
Biological networks constructed from varied data can be used to map cellular function, but each data type has limitations. Network integration promises to address these limitations by combining and automatically weighting input information to obtain a more accurate and comprehensive representation o...
Saved in:
Published in | Nature methods Vol. 19; no. 10; pp. 1250 - 1261 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.10.2022
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Biological networks constructed from varied data can be used to map cellular function, but each data type has limitations. Network integration promises to address these limitations by combining and automatically weighting input information to obtain a more accurate and comprehensive representation of the underlying biology. We developed a deep learning-based network integration algorithm that incorporates a graph convolutional network framework. Our method, BIONIC (Biological Network Integration using Convolutions), learns features that contain substantially more functional information compared to existing approaches. BIONIC has unsupervised and semisupervised learning modes, making use of available gene function annotations. BIONIC is scalable in both size and quantity of the input networks, making it feasible to integrate numerous networks on the scale of the human genome. To demonstrate the use of BIONIC in identifying new biology, we predicted and experimentally validated essential gene chemical–genetic interactions from nonessential gene profiles in yeast.
BIONIC uses a deep learning framework for accurate and scalable integration of biological networks. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 D.T.F. conceived and developed the method and computational experiments. S.C.L. and M.Y. performed the chemical–genetic screens. Z.L. provided resources for the TS mutant collection. L.A.V.I. preprocessed and provided the chemical–genetic data. H.O. provided the chemical matter and information about the screened compounds. S.C.L. and Z.L. constructed the drug-hypersensitive TS mutant collection. K.I.-N., D.Y. and H.O. performed the jervine biochemical validation. D.T.F., S.C.L., Y.Y., Y.O., B.W., G.D.B. and C.B. wrote the manuscript. B.W., G.D.B. and C.B. conceived and supervised the project. Author contributions |
ISSN: | 1548-7091 1548-7105 1548-7105 |
DOI: | 10.1038/s41592-022-01616-x |